Replies to post #20786 on Lifeline Biotechnologies Inc (LLBO)

[Domains]

Yes we have relevant information: As of today Cyrcadia has not raised the 1.5 million dollar needed to exercise its right to buy the LLBO patents before June 30th 2017.

Now, the questions are:

- Why such an "incredible" product is not able to raise such an small amount of money?
- Why, after nearly 2 years of clinical trials in two hospitals, they have not been able to enroll the 173 needed patients?
- Why don't we have up-to-date data on the number of patients enrolled in the trial and the "new" estimated completion date?
- Why LLBO does not inform its investors and keeps, for itself, the information transmitted to them by Cyrcadia?
- Why LLBO's stock price does not even have a fraction of the value it should have if the data we have it's true?

Get ready for, at least, another year without news!

[voo]

Sometimes no news is better than bad news. Same deals, same os. No dilution. So still in the game!!!

What did you think? That in an annual report there would be statements about the trials? That's not realistic! Wait and Patience.... that's all we can...